Caliber Imaging & Diagnostics Welcomes Updated European Guideline on Basal Cell Carcinoma That Praises Confocal Microscopy
9/16/2013 9:30:21 AM
ROCHESTER, N.Y. and BOSTON, Sept. 16, 2013 (GLOBE NEWSWIRE) -- Caliber Imaging & Diagnostics (Caliber I.D.), formerly Lucid, Inc. (OTCQB:LCDX), welcomes the recent update to the Guideline on Basal Cell Carcinoma published by the European Dermatology Forum. The updated guideline identifies confocal microscopy as one of three emerging techniques in digital imaging diagnostics and reports that confocal microscopy "has shown high diagnostic accuracy for the diagnosis of basal cell carcinoma."
Help employers find you! Check out all the jobs and post your resume.
comments powered by